Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape
Authors:
- Xinyu WuXWXinyu Wu
- Margareta GoMGMargareta Go
- Julie V. NguyenJNJulie V. Nguyen
- Bernadine G. C. LuBLBernadine G. C. Lu
- Kathleen ZeglinskiKZKathleen Zeglinski
- Kym N. LowesKLKym N. Lowes
- Dale J. CallejaDCDale J. Calleja
- Jeffrey P. MitchellJMJeffrey P. Mitchell
- Guillaume LesseneGLGuillaume Lessene
- David KomanderDKDavid Komander
- Matthew E. CallMCMatthew E. Call
Open Access
- 23 July 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-18
Abstract
Papain-like protease (PLpro) is an attractive drug target for SARS-CoV-2 because it is essential for viral replication, cleaving viral poly-proteins pp1a and pp1ab, and has de-ubiquitylation and de-ISGylation activities, affecting innate immune responses. We employ Deep Mutational Scanning to evaluate the mutational effects on PLpro enzymatic activity and protein stability in mammalian cells. We confirm features of the active site and identify mutations in neighboring residues that alter activity. We characterize residues responsible for substrate binding and demonstrate that although residues in the blocking loop are remarkably tolerant to mutation, blocking loop flexibility is important for function. We additionally find a connected network of mutations affecting activity that extends far from the active site. We leverage our library to identify drug-escape variants to a common PLpro inhibitor scaffold and predict that plasticity in both the S4 pocket and blocking loop sequence should be considered during the drug design process.Keywords
All Related Versions
This publication has 76 references indexed in Scilit:
- A Patent Review on SARS Coronavirus Papain‐Like Protease (PLpro) InhibitorsChemMedChem, 2023
- High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitorsProtein & Cell, 2021
- Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 BindingCell, 2020
- The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compoundsAntiviral Research, 2015
- Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site featuresAntiviral Research, 2014
- The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch MechanismImmunity, 2013
- Emerging Role of ISG15 in Antiviral ImmunityCell, 2010
- Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like proteaseArchives of Biochemistry and Biophysics, 2007
- Practical Methods of Optimization2000
- Structure of papain refined at 1.65 Å resolutionJournal of Molecular Biology, 1984